Leads an emerging regulatory consulting company that provides regulatory planning, interaction, and submission services

Developed regulatory consulting services for CCRM (a National Centre of Excellence focused on regenerative medicine)

Planned 2 Canadian CAR-T New Drug Submissions for Celgene

Led teams at Health Canada responsible for developing guidance for biosimilars, transplant material, and cell and gene therapies

• Supported their Therapeutic Products Classification Committee

• Chaired the Cells, Tissues, and Organs Classification Committee

• Championed international harmonization initiatives

An active member of the ISCT North American and Legislative Regulatory Affairs Committee and Health Canada’s Cell Therapy Stakeholder Grou